Product Description:

• 
  

  The world’s first recombinant treatment available for the prevention of bleeding in adults and children suffering from congenital factor XIII (FXIII) A-subunit deficiency.

  
  

How to use:

• 
  

  Start of treatment with NovoThirteen® should be supervised by a doctor with experience in rare bleeding conditions.

  
  


• 
  

  Following treatment cycles should also be supervised by a doctor for a period of time.

  
  


• 
  

  Always use this medicine exactly as your doctor has told you.

  
  


• 
  

  Check with your doctor or healthcare professional if you are not sure.

  
  


• NovoThirteen® is given as an injection into a vein. Your dose will depend on your body weight

Caution & Warnings:

• 
  

  Contact your doctor immediately, or go to the accident and emergency department at your nearest hospital if you have an allergic reaction.

  
  

Side Effects:

• Headache - local reaction around the injection site such as redness, itchiness, tenderness, pain or discomfort - pain in the legs or arms - frequent infections, such as fever, severe chills, sore throat or mouth ulcers which may be symptoms of a lack of white blood cells

Ingredients:

• Recombinant coagulation factor XIII (rFXIII), which is also called catridecacog (rys)